These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The hemodynamic effects of calcium channel blocking agents: a brief review. Kieval J; Myerburg RJ Angiology; 1982 Aug; 33(8):516-21. PubMed ID: 6287888 [No Abstract] [Full Text] [Related]
9. Calcium channel blockade in smooth muscle of the human upper urinary tract. I. Effects on depolarization-induced activation. Hertle L; Nawrath H J Urol; 1984 Dec; 132(6):1265-9. PubMed ID: 6094847 [TBL] [Abstract][Full Text] [Related]
10. Excitation-contraction coupling in cardiac and vascular smooth muscle: modification by calcium-entry blockade. McCall D Circulation; 1987 Jun; 75(6 Pt 2):V3-14. PubMed ID: 2436829 [TBL] [Abstract][Full Text] [Related]
11. Calcium entry blocker activity of cyproheptadine in isolated cardiovascular preparations. Winquist RJ; Siegl PK; Baskin EP; Bohn DL; Morgan G; Wallace AA J Pharmacol Exp Ther; 1984 Jul; 230(1):103-9. PubMed ID: 6747822 [TBL] [Abstract][Full Text] [Related]
12. Role of sodium-calcium exchange and effects of calcium entry blockers on endothelial-mediated responses in rat isolated aorta. Schoeffter P; Miller RC Mol Pharmacol; 1986 Jul; 30(1):53-7. PubMed ID: 3014308 [TBL] [Abstract][Full Text] [Related]
13. Tissue selectivity of the novel calcium antagonist sesamodil fumarate in isolated smooth muscles and cardiac muscles. Nishimura K; Miyawaki N; Yamauchi H; Iso T Arzneimittelforschung; 1990 Mar; 40(3):244-8. PubMed ID: 2112000 [TBL] [Abstract][Full Text] [Related]
14. Effects of calcium entry blockers not connected with calcium channels inhibition. Raddino R; Poli E; Ferrari R; Visioli O Gen Pharmacol; 1987; 18(4):431-6. PubMed ID: 2440761 [TBL] [Abstract][Full Text] [Related]
15. Bepridil hydrochloride alters potential-dependent and receptor-operated calcium channels in vascular smooth muscle of rabbit aorta. Flaim SF; Ratz PH; Swigart SC; Gleason MM J Pharmacol Exp Ther; 1985 Jul; 234(1):63-71. PubMed ID: 2409274 [TBL] [Abstract][Full Text] [Related]
16. Inhibiting effect of diltiazem on intracellular Ca2+ release in vascular smooth muscle. Saida K; van Breemen C Blood Vessels; 1983; 20(2):105-8. PubMed ID: 6824789 [No Abstract] [Full Text] [Related]
17. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium. Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975 [TBL] [Abstract][Full Text] [Related]
18. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms. Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of various L-type and T-type calcium antagonists on electrically generated, potassium-induced and carbachol-induced contractions of porcine detrusor muscle. Badawi JK; Li H; Langbein S; Kamp S; Guzman S; Bross S J Comp Physiol B; 2006 Jun; 176(5):429-39. PubMed ID: 16425017 [TBL] [Abstract][Full Text] [Related]
20. On the mechanism of action of calcium antagonists. Andersson KE; Högestätt ED Acta Med Scand Suppl; 1984; 681():11-24. PubMed ID: 6328899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]